|
2025-03-07 |
2025-03-07 |
S
Sale
|
Keenan Greg
Chief Medical Officer
Officer
|
8,305
-5.1%
8.23
USD 68,350
|
8,305
-5.1%
|
8.23
|
USD 68,350
|
|
|
2025-03-04 |
2025-03-04 |
S
Sale
|
Greenleaf Peter
Chief Executive Officer
Executive Director
|
164,947
-8.4%
7.92
USD 1,306,380
|
164,947
-8.4%
|
7.92
|
USD 1,306,380
|
|
|
2025-03-04 |
2025-03-04 |
S
Sale
|
Miller Joseph M
Chief Financial Officer
Officer
|
56,154
-8.9%
7.92
USD 444,740
|
56,154
-8.9%
|
7.92
|
USD 444,740
|
|
|
2025-03-04 |
2025-03-04 |
S
Sale
|
Robertson Stephen P.
EVP, General Counsel
Officer
|
57,607
-10.2%
7.92
USD 456,247
|
57,607
-10.2%
|
7.92
|
USD 456,247
|
|
|
2025-03-04 |
2025-03-04 |
S
Sale
|
Donley Matthew Maxwell
Chief Operating Officer
Officer
|
58,991
-8.0%
7.92
USD 467,209
|
58,991
-8.0%
|
7.92
|
USD 467,209
|
|
|
2025-03-04 |
2025-03-04 |
B
Purchase
|
TANG KEVIN
Non-Executive Director
|
100,000
+1.0%
8.09
USD 809,000
|
100,000
+1.0%
|
8.09
|
USD 809,000
|
|
|
2025-03-04 |
2025-03-04 |
B
Purchase
|
TANG KEVIN
Non-Executive Director
|
500,000
+5.3%
7.92
USD 3,960,000
|
500,000
+5.3%
|
7.92
|
USD 3,960,000
|
|
|
2025-03-04 |
2025-03-04 |
B
Purchase
|
TANG KEVIN
Non-Executive Director
|
148,038
+1.6%
8.00
USD 1,184,304
|
148,038
+1.6%
|
8.00
|
USD 1,184,304
|
|
|
2025-03-04 |
2025-03-03 |
S
Sale
|
Keenan Greg
Chief Medical Officer
Officer
|
12,239
-7.0%
8.00
USD 97,912
|
12,239
-7.0%
|
8.00
|
USD 97,912
|
|
|
2025-03-04 |
2025-03-03 |
S
Sale
|
Greenleaf Peter
Chief Executive Officer
Executive Director
|
195,593
-9.1%
8.00
USD 1,564,744
|
195,593
-9.1%
|
8.00
|
USD 1,564,744
|
|
|
2025-03-04 |
2025-03-03 |
S
Sale
|
Miller Joseph M
Chief Financial Officer
Officer
|
61,859
-8.9%
8.00
USD 494,872
|
61,859
-8.9%
|
8.00
|
USD 494,872
|
|
|
2025-03-04 |
2025-03-03 |
S
Sale
|
Robertson Stephen P.
EVP, General Counsel
Officer
|
64,872
-10.3%
8.00
USD 518,976
|
64,872
-10.3%
|
8.00
|
USD 518,976
|
|
|
2025-03-04 |
2025-03-03 |
S
Sale
|
Donley Matthew Maxwell
Chief Operating Officer
Officer
|
65,902
-8.2%
8.00
USD 527,216
|
65,902
-8.2%
|
8.00
|
USD 527,216
|
|
|
2025-03-04 |
2025-03-03 |
B
Purchase
|
TANG KEVIN
Non-Executive Director
|
351,962
+3.9%
8.02
USD 2,822,735
|
351,962
+3.9%
|
8.02
|
USD 2,822,735
|
|
|
2025-03-04 |
2025-03-03 |
B
Purchase
|
TANG KEVIN
Non-Executive Director
|
100,720
+1.1%
7.97
USD 802,738
|
100,720
+1.1%
|
7.97
|
USD 802,738
|
|
|
2025-03-04 |
2025-02-28 |
B
Purchase
|
TANG KEVIN
Non-Executive Director
|
399,280
+4.7%
7.85
USD 3,134,348
|
399,280
+4.7%
|
7.85
|
USD 3,134,348
|
|
|
2024-12-09 |
2024-12-09 |
B
Purchase
|
TANG KEVIN
Non-Executive Director
|
500,000
+6.3%
9.09
USD 4,545,000
|
500,000
+6.3%
|
9.09
|
USD 4,545,000
|
|
|
2024-12-09 |
2024-12-06 |
B
Purchase
|
TANG KEVIN
Non-Executive Director
|
400,000
+5.3%
9.01
USD 3,604,000
|
400,000
+5.3%
|
9.01
|
USD 3,604,000
|
|
|
2024-12-09 |
2024-12-05 |
B
Purchase
|
TANG KEVIN
Non-Executive Director
|
300,000
+4.1%
8.91
USD 2,673,000
|
300,000
+4.1%
|
8.91
|
USD 2,673,000
|
|
|
2024-11-12 |
2024-11-11 |
S
Sale
|
Bailey Jeffrey Allen
Non-Executive Director
|
4,557
-25.4%
8.43
USD 38,416
|
4,557
-25.4%
|
8.43
|
USD 38,416
|
|
|
2024-11-12 |
2024-11-11 |
S
Sale
|
Smith Karen L.
Non-Executive Director
|
5,241
-29.3%
8.43
USD 44,182
|
5,241
-29.3%
|
8.43
|
USD 44,182
|
|
|
2024-08-08 |
2024-08-06 |
S
Sale
|
Habig Scott Michael
Chief Commercial Officer
Officer
|
18,249
-3.8%
5.31
USD 96,902
|
18,249
-3.8%
|
5.31
|
USD 96,902
|
|
|
2024-05-22 |
2024-05-21 |
S
Sale
|
Balakrishnan Brinda
Non-Executive Director
|
520
-2.9%
5.74
USD 2,985
|
520
-2.9%
|
5.74
|
USD 2,985
|
|
|
2024-05-22 |
2024-05-21 |
S
Sale
|
MacKay-Dunn R. Hector
Non-Executive Director
|
5,630
-23.2%
5.74
USD 32,316
|
5,630
-23.2%
|
5.74
|
USD 32,316
|
|
|
2024-05-22 |
2024-05-21 |
S
Sale
|
MacKay-Dunn R. Hector
Non-Executive Director
|
5,630
-23.2%
5.74
USD 32,316
|
5,630
-23.2%
|
5.74
|
USD 32,316
|
|
|
2024-05-22 |
2024-05-21 |
S
Sale
|
Billen Daniel
Non-Executive Director
|
5,252
-15.7%
5.74
USD 30,146
|
5,252
-15.7%
|
5.74
|
USD 30,146
|
|
|
2024-05-22 |
2024-05-21 |
S
Sale
|
Billen Daniel
Non-Executive Director
|
5,252
-15.7%
5.74
USD 30,146
|
5,252
-15.7%
|
5.74
|
USD 30,146
|
|
|
2024-05-22 |
2024-05-21 |
S
Sale
|
Leversage Jill
Non-Executive Director
|
5,610
-30.3%
5.74
USD 32,201
|
5,610
-30.3%
|
5.74
|
USD 32,201
|
|
|
2024-05-22 |
2024-05-21 |
S
Sale
|
Leversage Jill
Non-Executive Director
|
5,610
-30.3%
5.74
USD 32,201
|
5,610
-30.3%
|
5.74
|
USD 32,201
|
|
|
2024-05-22 |
2024-05-21 |
S
Sale
|
Jayne David R.W.
Non-Executive Director
|
4,946
-10.0%
5.74
USD 28,390
|
4,946
-10.0%
|
5.74
|
USD 28,390
|
|
|
2024-05-22 |
2024-05-21 |
S
Sale
|
Jayne David R.W.
Non-Executive Director
|
4,946
-10.0%
5.74
USD 28,390
|
4,946
-10.0%
|
5.74
|
USD 28,390
|
|
|
2024-05-22 |
2024-05-21 |
S
Sale
|
MacKay-Dunn, R. Hector
Director of Issuer
Non-Executive Director
|
5,630
-42.6%
5.74
USD 32,316
|
5,630
-42.6%
|
5.74
|
USD 32,316
|
|
|
2024-03-07 |
2024-03-06 |
S
Sale
|
Habig Scott Michael
Chief Commercial Officer
Officer
|
17,777
-3.6%
5.60
USD 99,551
|
17,777
-3.6%
|
5.60
|
USD 99,551
|
|
|
2024-03-07 |
2024-03-06 |
S
Sale
|
Greenleaf Peter
Chief Executive Officer
Executive Director
|
126,981
-7.7%
5.60
USD 711,094
|
126,981
-7.7%
|
5.60
|
USD 711,094
|
|
|
2024-03-07 |
2024-03-06 |
S
Sale
|
Miller Joseph M
Chief Financial Officer
Officer
|
34,811
-6.6%
5.60
USD 194,942
|
34,811
-6.6%
|
5.60
|
USD 194,942
|
|
|
2024-03-07 |
2024-03-06 |
S
Sale
|
Robertson Stephen P.
EVP, General Counsel
Officer
|
57,745
-11.5%
5.60
USD 323,372
|
57,745
-11.5%
|
5.60
|
USD 323,372
|
|
|
2024-03-07 |
2024-03-06 |
S
Sale
|
Donley Matthew Maxwell
EVP, Ops & Strategy
Officer
|
40,665
-6.5%
5.51
USD 224,064
|
40,665
-6.5%
|
5.51
|
USD 224,064
|
|
|
2024-02-29 |
2024-02-27 |
S
Sale
|
Knappertz Volker
EVP, Research and Development
Officer
|
4,930
-1.5%
6.10
USD 30,073
|
4,930
-1.5%
|
6.10
|
USD 30,073
|
|
|
2024-02-29 |
2024-02-27 |
PS
Planned sale
|
Knappertz, Volker
Senior Officer of Issuer
Officer
|
4,930
-16.0%
6.10
USD 30,073
|
4,930
-16.0%
|
6.10
|
USD 30,073
|
|
|
2024-02-26 |
2024-02-20 |
PP
Planned purchase
|
Donley, Matthew
Senior Officer of Issuer
Officer
|
4,930
+7.9%
4,930.00
CAD 18,012,361
|
4,930
+7.9%
|
4,930.00
|
CAD 24,304,900
|
|
|
2024-02-22 |
2024-02-20 |
S
Sale
|
Habig Scott Michael
Chief Commercial Officer
Officer
|
15,867
-3.1%
5.48
USD 86,951
|
15,867
-3.1%
|
5.48
|
USD 86,951
|
|
|
2024-02-22 |
2024-02-20 |
S
Sale
|
Knappertz Volker
EVP, Research and Development
Officer
|
25,146
-7.2%
5.48
USD 137,800
|
25,146
-7.2%
|
5.48
|
USD 137,800
|
|
|
2023-05-23 |
2023-05-23 |
S
Sale
|
Leversage Jill
Non-Executive Director
|
4,815
-20.6%
11.26
USD 54,217
|
4,815
-20.6%
|
11.26
|
USD 54,217
|
|
|
2023-05-23 |
2023-05-23 |
S
Sale
|
Jayne David R.W.
Non-Executive Director
|
8,733
-15.0%
11.26
USD 98,334
|
8,733
-15.0%
|
11.26
|
USD 98,334
|
|
|
2023-05-23 |
2023-05-23 |
S
Sale
|
MacKay-Dunn R. Hector
Non-Executive Director
|
4,818
-16.6%
11.26
USD 54,251
|
4,818
-16.6%
|
11.26
|
USD 54,251
|
|
|
2023-05-23 |
2023-05-23 |
S
Sale
|
Billen Daniel
Non-Executive Director
|
4,650
-12.2%
11.26
USD 52,359
|
4,650
-12.2%
|
11.26
|
USD 52,359
|
|
|
2023-05-23 |
2023-05-19 |
S
Sale
|
Hagan Joseph P
Non-Executive Director
|
272
-2.2%
10.58
USD 2,878
|
272
-2.2%
|
10.58
|
USD 2,878
|
|
|
2023-03-06 |
2023-03-02 |
S
Sale
|
Robertson Stephen P.
EVP, General Counsel
Officer
|
19,402
-6.0%
8.94
USD 173,454
|
19,402
-6.0%
|
8.94
|
USD 173,454
|
|
|
2023-03-06 |
2023-03-02 |
S
Sale
|
Greenleaf Peter
Chief Executive Officer
Executive Director
|
32,750
-3.2%
8.94
USD 292,785
|
32,750
-3.2%
|
8.94
|
USD 292,785
|
|
|
2023-03-06 |
2023-03-02 |
B
Purchase
|
MILNE GEORGE M JR
Non-Executive Director
|
20,000
+40.0%
8.91
USD 178,284
|
20,000
+40.0%
|
8.91
|
USD 178,284
|
|
|
2023-03-06 |
2023-03-02 |
S
Sale
|
Miller Joseph M
Chief Financial Officer
Officer
|
11,296
-3.3%
8.94
USD 100,986
|
11,296
-3.3%
|
8.94
|
USD 100,986
|
|
|
2022-11-23 |
2022-11-21 |
PP
Planned purchase
|
Donley Matthew Maxwell
Ex VP, Internal Operations
Officer
|
10,000
+55.8%
4.66
USD 46,600
|
10,000
+55.8%
|
4.66
|
USD 46,600
|
|
|
2022-11-14 |
2022-11-09 |
B
Purchase
|
Habig Scott Michael
Chief Commercial Officer
Officer
|
5,000
+inf%
5.02
USD 25,075
|
5,000
+inf%
|
5.02
|
USD 25,075
|
|
|
2022-11-09 |
2022-11-07 |
B
Purchase
|
Martin Michael Robert
Chief Business Officer
Officer
|
30,000
+50.4%
5.16
USD 154,800
|
30,000
+50.4%
|
5.16
|
USD 154,800
|
|
|
2022-03-11 |
2022-03-09 |
B
Purchase
|
MacKay-Dunn R. Hector
Non-Executive Director
|
5,000
+83.3%
11.00
USD 54,985
|
5,000
+83.3%
|
11.00
|
USD 54,985
|
|
|
2022-03-08 |
2022-03-04 |
B
Purchase
|
MILNE GEORGE M JR
Non-Executive Director
|
5,000
+11.1%
10.82
USD 54,100
|
5,000
+11.1%
|
10.82
|
USD 54,100
|
|
|
2022-03-04 |
2022-03-02 |
S
Sale
|
Donley Matthew Maxwell
Ex VP, Intern'l Operations
Officer
|
3,052
-15.8%
12.01
USD 36,655
|
3,052
-15.8%
|
12.01
|
USD 36,655
|
|
|
2022-03-04 |
2022-03-02 |
S
Sale
|
Colao Massimilano
Chief Commercial Officer
Officer
|
3,205
-19.2%
12.01
USD 38,492
|
3,205
-19.2%
|
12.01
|
USD 38,492
|
|
|
2022-03-04 |
2022-03-02 |
S
Sale
|
Greenleaf Peter
Chief Executive Officer
Executive Director
|
9,068
-21.6%
12.01
USD 108,907
|
9,068
-21.6%
|
12.01
|
USD 108,907
|
|
|
2022-03-04 |
2022-03-02 |
S
Sale
|
Miller Joseph M
Chief Financial Officer
Officer
|
3,060
-31.6%
12.01
USD 36,751
|
3,060
-31.6%
|
12.01
|
USD 36,751
|
|
|
2022-03-04 |
2022-03-02 |
S
Sale
|
Huizinga Robert Bindert
EVP of Research
Officer
|
4,849
-6.5%
12.01
USD 58,236
|
4,849
-6.5%
|
12.01
|
USD 58,236
|
|
|
2022-03-04 |
2022-03-02 |
S
Sale
|
Martin Michael Robert
Chief Business Officer
Officer
|
4,849
-7.5%
12.01
USD 58,236
|
4,849
-7.5%
|
12.01
|
USD 58,236
|
|
|
2022-03-04 |
2022-03-02 |
S
Sale
|
Solomons Neil
Chief Medical Officer
Officer
|
4,846
-5.1%
12.01
USD 58,200
|
4,846
-5.1%
|
12.01
|
USD 58,200
|
|
|
2022-01-04 |
2022-01-03 |
PS
Planned sale
|
Hagan Joseph P
Non-Executive Director
|
634
-15.3%
23.29
USD 14,766
|
634
-15.3%
|
23.29
|
USD 14,766
|
|
|
2022-01-04 |
2022-01-03 |
PS
Planned sale
|
Hagan Joseph P
Non-Executive Director
|
39,366
-90.5%
22.58
USD 888,884
|
39,366
-90.5%
|
22.58
|
USD 888,884
|
|
|
2021-12-15 |
2021-12-13 |
B
Purchase
|
Leversage Jill
Non-Executive Director
|
1,600
+43.2%
20.04
USD 32,064
|
1,600
+43.2%
|
20.04
|
USD 32,064
|
|
|
2021-11-12 |
2021-11-11 |
PS
Planned sale
|
Solomons Neil
Chief Medical Officer
Officer
|
100,000
-53.4%
28.89
USD 2,889,000
|
100,000
-53.4%
|
28.89
|
USD 2,889,000
|
|
|
2021-11-12 |
2021-11-11 |
PS
Planned sale
|
Martin Michael Robert
Chief Business Officer
Officer
|
11,000
-16.5%
29.50
USD 324,500
|
11,000
-16.5%
|
29.50
|
USD 324,500
|
|
|
2021-11-12 |
2021-11-11 |
PS
Planned sale
|
Martin Michael Robert
Chief Business Officer
Officer
|
29,000
-30.3%
28.82
USD 835,780
|
29,000
-30.3%
|
28.82
|
USD 835,780
|
|
|
2021-11-12 |
2021-11-10 |
PS
Planned sale
|
Solomons Neil
Chief Medical Officer
Officer
|
10,000
-10.3%
30.55
USD 305,500
|
10,000
-10.3%
|
30.55
|
USD 305,500
|
|
|
2021-11-12 |
2021-11-10 |
PS
Planned sale
|
Solomons Neil
Chief Medical Officer
Officer
|
90,000
-48.1%
31.17
USD 2,805,300
|
90,000
-48.1%
|
31.17
|
USD 2,805,300
|
|
|
2021-11-12 |
2021-11-10 |
PS
Planned sale
|
Martin Michael Robert
Chief Business Officer
Officer
|
10,000
-13.0%
30.55
USD 305,500
|
10,000
-13.0%
|
30.55
|
USD 305,500
|
|
|
2021-11-12 |
2021-11-10 |
PS
Planned sale
|
Martin Michael Robert
Chief Business Officer
Officer
|
50,000
-39.4%
31.26
USD 1,563,000
|
50,000
-39.4%
|
31.26
|
USD 1,563,000
|
|
|
2021-11-12 |
2021-11-09 |
PS
Planned sale
|
Solomons Neil
Chief Medical Officer
Officer
|
50,000
-36.4%
30.17
USD 1,508,500
|
50,000
-36.4%
|
30.17
|
USD 1,508,500
|
|
|
2021-11-12 |
2021-11-09 |
PS
Planned sale
|
Martin Michael Robert
Chief Business Officer
Officer
|
50,000
-28.3%
30.17
USD 1,508,500
|
50,000
-28.3%
|
30.17
|
USD 1,508,500
|
|
